{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:48:08Z","timestamp":1787932088273,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T00:00:00Z","timestamp":1704499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"DOI":"10.1007\/s10006-023-01204-z","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T19:08:37Z","timestamp":1704481717000},"page":"785-793","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study"],"prefix":"10.1007","volume":"28","author":[{"given":"Eleni","family":"Besi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3234-8899","authenticated-orcid":false,"given":"Panagiotis","family":"Pitros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,6]]},"reference":[{"issue":"5","key":"1204_CR1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T et al (2022) American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 Update. J Oral Maxillofac Surg 80(5):920\u2013943. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"1204_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117. https:\/\/doi.org\/10.1016\/s0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"issue":"5 Suppl","key":"1204_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA et al (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20132009 update. J Oral Maxillofac Surg 67(5 Suppl):2\u201312. https:\/\/doi.org\/10.1016\/j.joms.2009.01.009","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"1204_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72(10):1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"1204_CR5","unstructured":"Scottish Dental Clinical Effectiveness Programme. (2017) Oral health management of patients at risk of medicationrelated osteonecrosis of the jaw. Dental Clinical Guidance.\u00a0 http:\/\/www.sdcep.org.uk\/wpcontent\/uploads\/2017\/04\/SDCEP-Oral-Health-Management-of-Patients-at-Risk-of-MRONJ-Guidance-full.pdf"},{"issue":"5","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","volume":"68","author":"TL Aghaloo","year":"2010","unstructured":"Aghaloo TL, Felsenfeld AL, Tetradis S (2010) Osteonecrosis of the jaw in a patient on denosumab. J Oral Maxillofac Surg 68(5):959\u2013963. https:\/\/doi.org\/10.1016\/j.joms.2009.10.010","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"1204_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","volume":"43","author":"S Otto","year":"2015","unstructured":"Otto S, Troltzsch M, Jambrovic V et al (2015) Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development? J Craniomaxillofac Surg 43(6):847\u2013854. https:\/\/doi.org\/10.1016\/j.jcms.2015.03.039","journal-title":"J Craniomaxillofac Surg"},{"issue":"8","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","volume":"136","author":"O Filleul","year":"2010","unstructured":"Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136(8):1117\u20131124. https:\/\/doi.org\/10.1007\/s00432-010-0907-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"1204_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S1079-2104(98)90029-4","volume":"85","author":"RE Marx","year":"1998","unstructured":"Marx RE, Carlson ER, Eichstaedt RM et al (1998) Platelet-rich plasma growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol 85:638\u201346","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/gfsc.Gfsc_19_18","volume":"1","author":"M Fabbro","year":"2018","unstructured":"Fabbro M, Taschieri S, Goker F (2018) Platelet concentrates as an adjunctive therapy for medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. Int J Growth Fact Stem Cells Dentist 1(2):48. https:\/\/doi.org\/10.4103\/gfsc.Gfsc_19_18","journal-title":"Int J Growth Fact Stem Cells Dentist"},{"issue":"9","key":"1204_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","volume":"52","author":"JW Kim","year":"2014","unstructured":"Kim JW, Kim SJ, Kim MR (2014) Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study. Br J Oral Maxillofac Surg 52(9):854\u2013859. https:\/\/doi.org\/10.1016\/j.bjoms.2014.07.256","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"3","key":"1204_CR12","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/j.tripleo.2005.07.011","volume":"101","author":"J Choukroun","year":"2006","unstructured":"Choukroun J, Diss A, Simonpieri A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e56-60. https:\/\/doi.org\/10.1016\/j.tripleo.2005.07.011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.tripleo.2005.07.010","volume":"101","author":"DM Dohan","year":"2006","unstructured":"Dohan DM, Choukroun J, Diss A et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e51-5. https:\/\/doi.org\/10.1016\/j.tripleo.2005.07.010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"1204_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/biology10040317","volume":"10","author":"E Mijiritsky","year":"2021","unstructured":"Mijiritsky E, Assaf HD, Peleg O et al (2021) Use of PRP, PRF and CGF in periodontal regeneration and facial rejuvenation-a narrative review. Biology (Basel) 10(4):317. https:\/\/doi.org\/10.3390\/biology10040317","journal-title":"Biology (Basel)"},{"key":"1204_CR15","unstructured":"Pinto N, Temmerman A, Castro A, et al (2017) Guidelines for the use of L-PRF flow charts: step by step approach leucocytes and platelet rich fibrin in different intra-oral applications applying the IntraSpin \u2122 Concept. Enhanced natural healing in dentistry; https:\/\/kuleuvencongres.be\/ENHD2018\/guidelines-for-use-of-l-prf.pdf"},{"issue":"5","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","volume":"48","author":"M Mozzati","year":"2012","unstructured":"Mozzati M, Gallesio G, Arata V et al (2012) Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32 cases. Oral Oncol 48(5):469\u2013474. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.12.004","journal-title":"Oral Oncol"},{"issue":"10","key":"1204_CR17","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","volume":"12","author":"SA Khan","year":"1997","unstructured":"Khan SA, Kanis JA, Vasikaran S et al (1997) Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res 12(10):1700\u20131707. https:\/\/doi.org\/10.1359\/jbmr.1997.12.10.1700","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1204_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, O\u2019Ryan FS, Gordon NP et al (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68(2):243\u2013253. https:\/\/doi.org\/10.1016\/j.joms.2009.03.050","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"1204_CR19","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ijom.2015.01.014","volume":"44","author":"M Nisi","year":"2015","unstructured":"Nisi M, La Ferla F, Karapetsa D et al (2015) Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: a multivariate analysis. Int J Oral Maxillofac Surg 44(5):586\u2013591. https:\/\/doi.org\/10.1016\/j.ijom.2015.01.014","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"6","key":"1204_CR20","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1210\/jc.2007-2814","volume":"93","author":"HG Bone","year":"2008","unstructured":"Bone HG, Bolognese MA, Yuen CK et al (2008) Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. J Clin Endocrinol Metab 93(6):2149\u20132157. https:\/\/doi.org\/10.1210\/jc.2007-2814","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1204_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2014.10.015","volume":"51","author":"M Del Fabbro","year":"2015","unstructured":"Del Fabbro M, Gallesio G, Mozzati M (2015) Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer 51(1):62\u201374. https:\/\/doi.org\/10.1016\/j.ejca.2014.10.015","journal-title":"Eur J Cancer"},{"issue":"2","key":"1204_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.joms.2013.07.027","volume":"72","author":"SS Soydan","year":"2014","unstructured":"Soydan SS, Uckan S (2014) Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: technical report. J Oral Maxillofac Surg 72(2):322\u2013326. https:\/\/doi.org\/10.1016\/j.joms.2013.07.027","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08977190802636713","volume":"27","author":"DM Dohan Ehrenfest","year":"2009","unstructured":"Dohan Ehrenfest DM, de Peppo GM, Doglioli P et al (2009) Slow release of growth factors and thrombospondin-1 in Choukroun\u2019s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Fact 27(1):63\u201369. https:\/\/doi.org\/10.1080\/08977190802636713","journal-title":"Growth Fact"},{"issue":"5","key":"1204_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.tripleo.2009.06.044","volume":"108","author":"L He","year":"2009","unstructured":"He L, Lin Y, Hu X et al (2009) A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108(5):707\u2013713. https:\/\/doi.org\/10.1016\/j.tripleo.2009.06.044","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"7","key":"1204_CR25","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00784-016-2004-z","volume":"21","author":"T Asaka","year":"2017","unstructured":"Asaka T, Ohga N, Yamazaki Y et al (2017) Platelet-rich fibrin may reduce the risk of delayed recovery in tooth-extracted patients undergoing oral bisphosphonate therapy: a trial study. Clin Oral Investig 21(7):2165\u20132172. https:\/\/doi.org\/10.1007\/s00784-016-2004-z","journal-title":"Clin Oral Investig"},{"issue":"6","key":"1204_CR26","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1016\/j.oooo.2012.08.442","volume":"117","author":"MJ Heufelder","year":"2014","unstructured":"Heufelder MJ, Hendricks J, Remmerbach T et al (2014) Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 117(6):e429\u2013e435. https:\/\/doi.org\/10.1016\/j.oooo.2012.08.442","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"11","key":"1204_CR27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","volume":"41","author":"T Yamazaki","year":"2012","unstructured":"Yamazaki T, Yamori M, Ishizaki T et al (2012) Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg 41(11):1397\u20131403. https:\/\/doi.org\/10.1016\/j.ijom.2012.06.020","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"1204_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00784-016-1762-y","volume":"21","author":"A Matsumoto","year":"2017","unstructured":"Matsumoto A, Sasaki M, Schmelzeisen R et al (2017) Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Clin Oral Investig 21(1):127\u2013134. https:\/\/doi.org\/10.1007\/s00784-016-1762-y","journal-title":"Clin Oral Investig"},{"issue":"8","key":"1204_CR29","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","volume":"28","author":"T Hasegawa","year":"2017","unstructured":"Hasegawa T, Kawakita A, Ueda N, Japanese Study Group of Cooperative Dentistry with Medicine (JCDM) et al (2017) A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int 28(8):2465\u20132473. https:\/\/doi.org\/10.1007\/s00198-017-4063-7","journal-title":"Osteoporos Int"},{"issue":"3","key":"1204_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/odi.13556","volume":"27","author":"O Ristow","year":"2021","unstructured":"Ristow O, R\u00fcckschlo\u00df T, Moratin J et al (2021) Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake-a randomized pilot trial. Oral Dis 27(3):532\u2013546. https:\/\/doi.org\/10.1111\/odi.13556","journal-title":"Oral Dis"},{"key":"1204_CR31","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.4317\/jced.56837","volume":"12","author":"OT \u015eahin","year":"2020","unstructured":"\u015eahin OT, Ekmekcio\u011flu C, Aliyev T et al (2020) Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: an institution\u2019s experience. J Clin Exp Dent 12:e771\u2013e776. https:\/\/doi.org\/10.4317\/jced.56837","journal-title":"J Clin Exp Dent"},{"issue":"5","key":"1204_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C et al (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23(5):1341\u20131347. https:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"issue":"6","key":"1204_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","volume":"126","author":"FA Hallmer","year":"2018","unstructured":"Hallmer FA, G\u00f6trick B, Warfvinge G et al (2018) Prevalence, initiating factor and treatment outcome of medication-related osteonecrosis of the jaw-a four year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 126(6):477\u2013485. https:\/\/doi.org\/10.1016\/j.oooo.2018.08.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"10","key":"1204_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jcpe.12455","volume":"42","author":"E Gaudin","year":"2015","unstructured":"Gaudin E, Seidel L, Bacevic M et al (2015) Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 42(10):922\u2013932. https:\/\/doi.org\/10.1111\/jcpe.12455","journal-title":"J Clin Periodontol"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-023-01204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-023-01204-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-023-01204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T23:13:53Z","timestamp":1717370033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-023-01204-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,6]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1007\/s10006-023-01204-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3203658\/v1","asserted-by":"object"}]},"ISSN":["1865-1569"],"issn-type":[{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,6]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has received approval from the Oral Health Service, Quality Improvement Team of NHS Lothian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}